1995
Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. JAMA Dermatology 1995, 131: 432-5. PMID: 7726585, DOI: 10.1001/archderm.131.4.432.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyCutaneous T-cell lymphomaT-cell lymphomaSquamous cell carcinomaBasal cell carcinomaElectron beam therapyAdditional radiation therapyCell carcinomaCutaneous malignanciesOral psoralenAdditional therapyMalignant melanomaRadiation therapyBeam therapyTotal skin electron beam radiationFurther radiation therapyGroup of patientsNonmelanoma skin cancerAnecdotal case reportsPrevious large studiesTopical mechlorethamineHydrochloride therapyCase reportPatientsCarcinoma
1980
Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor
Cohen S, Stenn K, Braverman I, Beck G. Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980, 46: 2654-2666. PMID: 6778603, DOI: 10.1002/1097-0142(19801215)46:12<2654::aid-cncr2820461220>3.0.co;2-1.Peer-Reviewed Original ResearchConceptsStage of diseaseMycosis fungoidesPatient survivalClinicopathologic relationshipOccupational factorsSignificant prognostic variablesNew prognostic factorsCase-control studyPrognostic factorsPathogenic hypothesisSézary cellsHistologic stageHistopathologic materialVisceral manifestationsHistologic criteriaChemotherapeutic modalitiesSevere diseaseSkin lesionsPrognostic variablesSkin tumorsProbability of survivalFurther evaluationPatientsDiseaseStaging scheme